Inscription Capital, LLC

Position in BCRX — Biocryst Pharmaceuticals Inc

CIK 1767868 HOUSTON, TX

Position in BCRX

as of Mar 31, 2026 · filed Apr 20, 2026 Compact

Position Value

$128,481

New position

Shares Held

13,496

first reported quarter

Ownership

0.005%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2026

1 quarter on record

Voting authority Sole 64% Shared 0% None 36%

Healthcare · as of Mar 31, 2026

Inscription Capital, LLC holds $1,401,582 across 5 Drug Manufacturers - Specialty & Generic names. BCRX ranks #5 (9.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ELAN	Elanco Animal Health Inc	20,099	$480,969
2	TAK	Takeda Pharmaceutical Co Ltd	22,011	$407,643
3	ZTS	Zoetis Inc.	2,024	$239,257
4	ANIK	Anika Therapeutics, Inc.	10,016	$145,232
5	BCRX	Biocryst Pharmaceuticals Inc This page	13,496	$128,481

1 filing row on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$128,481	13,496	—	Shares	Sole	2026-04-20
No filing history on record for this holder in this stock.